Last updated on December 2018

Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer


Brief description of study

The purpose of this study is to evaluate the safety and efficacy of the study drug abemaciclib in participants with high risk, node positive, early stage, hormone receptor positive (HR+), human epidermal receptor 2 negative (HER2-), breast cancer.

Clinical Study Identifier: NCT03155997

Contact Investigators or Research Sites near you

Start Over

Takahiro Nakayama

Osaka International Cancer Institute
Osaka, Japan
0.09miles
  Connect »

Norikazu Masuda

National Hospital Organization Osaka National Hospital
Osaka, Japan
0.46miles
  Connect »

Yasuo Miyoshi

The Hospital of Hyogo College of Medecine
Nishinomiya, Japan
8.29miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.